Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Pусский | Português | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2010DISEASENETWORKREGISTRYPREDICTPROJECTSLOGIN
  
 
  
News of European HD Network -
--->News
[-]The Project
--->Sponsor
--->[+]Executive Committee
--->[+]Scientific and Bioethics Advis...
--->Central Coordination
--->Language Coordination
--->[+]Constitution
--->[+]Voting/Nomination
--->[+]Members
[-]Locations
--->[+]Austria
--->[+]Belgium
--->[+]Czech Republic
--->[+]Denmark
--->[+]Finland
--->[+]France
--->[+]Germany
--->[+]Italy
--->[+]Netherlands
--->[+]Norway
--->[+]Poland
--->[+]Portugal
--->[+]Russia
--->[-]Spain
--->Coordination
--->HD Associations
--->Alicante-Alcoy
--->Badajoz
--->Barcelona - Bellvitge
--->Barcelona - Clinic i Provincia...
--->Barcelona - Mutua de Terra...
--->Barcelona - Santa Creu i Sa...
--->Barcelona - Merced
--->Burgos
--->Granada
--->Fuenlabrada
--->Madrid - Clínico
--->Madrid - FJD
--->Madrid - RyC
--->Murcia
--->Oviedo
--->Palma de Mallorca
--->Pamplona
--->Sevilla
--->Sevilla-HUVRocio
--->Valencia
--->_Santiago
--->[+]Sweden
--->[+]Switzerland
--->[+]U.K.
[-]Working Groups
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[+]Biological Modifiers
--->[+]Biomarkers
--->[+]Brain and Tissue Banking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[+]Genetic Modifiers
--->[+]Health Economics
--->[+]Imaging
--->[+]Juvenile HD
--->[+]Motor Phenotype
--->[+]Neuroprotective Therapy
--->[+]Physiotherapy
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Approaches
--->[+]Symptomatic Research
--->[+]Youth
[+]Events
[+]Communication
--->Job Offers
5th Annual CHDI HD Therapeutics Conference: Back Home at the Parker Palm Springs

CHDI is delighted to announce that our 5th Annual Conference on HD Therapeutics will be held February 8-11, 2010, in Palm Springs, California. The conference program is currently being planned and will cover all aspects of drug discovery related to Huntington's disease.
Sessions will include:

  • Clinical Discovery: How Studies in HD Patients Can Inform Preclinical HD Research
  • Emerging Topics in Early HD Drug Discovery
  • In Vivo HD Models: Beyond the Rotarod
  • Understanding Huntingtin Function to Enable Drug Discovery
  • Exploring the Late Stage Portfolio: Challenges and Hurdles Associated with Multiple Modalities

Please join us at the Parker Hotel in Palm Springs and entertain new connections that might expose possible treatments for Huntington's disease.[back]
about us privacy statement disclaimer terms of use